The Latest in DMT Research: Leading Companies and Key Studies

Truffle Report put together this roundup of the top corporate and scientific developments involving the psychoactive compound N, N-dimethyltryptamine (DMT). Small Pharma is featured alongside a number of leading companies and key studies covering the latest in DMT.

In addition to Small Pharma’s research trials into DMT-assisted therapy for major depression disorder, the report covers other key studies of DMT including:

• Akome Biotech: Targeting Stroke and Parkinson’s Disease with DMT-Based Drug Formulas
• Algernon Pharmaceuticals: DMT for Stroke Patients
• Entheon Biomedical: DMT and DMT-Analogs to Treat Nicotine Addiction
• MindMed: Investigating the Safety and Efficacy of Intravenous Administration of DMT
• PharmaDrug: DMT to Prevent Vision Loss
• Psilera Bioscience: Developing Non-Hallucinogenic DMT-Derivatives
• Sairiyo Therapeutics: Exploring DMT’s Role in Improving Organ Transplant Safety
• Vocan Biotechnologies: Biosynthesizing DMT at Scale